Pear Therapeutics, INC.
Development of prescription digital therapeutics.
Based in MA
AI Overview
With $480K in lobbying spend across 13 quarterly filings, Pear Therapeutics, INC is an active lobbying client. They deploy 17 individual lobbyists Their lobbying covers 1 issue area. Active from 2020 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $180K |
| 2021 | $160K |
| 2022 | $120K |
| 2023 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Pear Therapeutics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to prescription digital therapeutics including S. 3532 - Prescription Digital Therapeutics to Support Recovery Act.
Issues related to prescription digital therapeutics including S. 3552 - Prescription Digital Therapeutics to Support Recovery Act.
Federal policy related to prescription digital therapeutics (no specific legislation).
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.